EUVIMEDEUVIMED entdecken
EditorialLeitlinie

Anticoagulation for atrial fibrillation after cardiac surgery: Do guidelines reflect the evidence?

Subhasis Chatterjee, Niv Ad, Vinay Badhwar, A Marc Gillinov, John H Alexander, Marc R Moon

The Journal of Thoracic and Cardiovascular Surgery · 2024

DOI: 10.1016/j.jtcvs.2023.03.026 ↗

Kurz gefasst

Editorial in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2024. Verfasst von Subhasis Chatterjee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Tex; Department of Cardiovascular Surgery, The Texas Heart Institute, …. Hauptthemen laut MEDLINE: Atrial Fibrillation, Cardiac Surgical Procedures, Stroke. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Texas Heart Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current expert consensus documents are based on limited eviPostoperative atrial fibrillation (POAF) is common after cardiac surgery, affecting approximately 30% (range, 20%-40%) of patients. Typically, POAF develops between postoperative days 2 and 4; with pharmacological intervention, POAF usually resolves within 24 hours, such that approximately 90% of patients have regained sinus rhythm at discharge. Medical management of atrial fibrillation (AF) rests on 2 foundations: (1) rate versus rhythm control and (2) oral anticoagulation (OAC) to reduce the risk for stroke and thromboembolism. Our assumption has been to treat POAF similarly; nonetheless, balancing stroke and thromboembolism risks with early perioperative bleeding risk remains problematic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCardiac Surgical ProceduresStrokeHumansBlood CoagulationAnticoagulantsRisk FactorsAdministration, Oral

Stichwörter der Autor:innen

anticoagulantsatrial fibrillationpostoperative complicationspractice guidelines, risk factorsstrokethromboembolism

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Tex; Department of Cardiovascular Surgery, The Texas Heart Institute, Houston, Tex. Electronic address: subhasis.chatterjee@bcm.edu.
  • Division of Cardiac Surgery, White Oak Medical Center, Adventist HealthCare, University of Maryland, Takoma Park, Md.
  • Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown, WVa.
  • Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio.
  • Division of Cardiology, Duke University School of Medicine & Duke Clinical Research Institute, Durham, NC.
  • Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Tex; Department of Cardiovascular Surgery, The Texas Heart Institute, Houston, Tex.

Förderung

  • Texas Heart Institute

Zitieren

APA

Chatterjee, S., Ad, N., Badhwar, V., Gillinov, A. M., Alexander, J. H., & Moon, M. R. (2024). Anticoagulation for atrial fibrillation after cardiac surgery: Do guidelines reflect the evidence?. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2023.03.026

Vancouver

Chatterjee S, Ad N, Badhwar V, Gillinov AM, Alexander JH, Moon MR. Anticoagulation for atrial fibrillation after cardiac surgery: Do guidelines reflect the evidence?. The Journal of Thoracic and Cardiovascular Surgery. 2024. doi:10.1016/j.jtcvs.2023.03.026

BibTeX
@article{Chatterjee2024,
  author = {Chatterjee, Subhasis and Ad, Niv and Badhwar, Vinay and Gillinov, A Marc and Alexander, John H and Moon, Marc R},
  title = {Anticoagulation for atrial fibrillation after cardiac surgery: Do guidelines reflect the evidence?},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2024},
  doi = {10.1016/j.jtcvs.2023.03.026}
}
Kostenlos starten →